White, Harvey D.; Steg, Ph. Gabriel; Szarek, Michael; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay M.; Erglis, Andrejs; Goodman, Shaun G.; Hanotin, Corinne; Harrington, Robert A.; Jukema, J Wouter; Lopes, Renato D.; Mahaffey, Kenneth W.; Moryusef, Angele; Pordy, Robert; Roe, Matthew T.; Sritara, Piyamitr; Tricoci, Pierluigi; Zeiher, Andreas M.; Schwartz, Gregory G.; Peršić, ViktorViše autora...
Citirajte ovaj rad
White, H. D., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R. ... Peršić, V. (2019). Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. European Heart Journal, 40. (33), 2801-2809. doi: 10.1093/eurheartj/ehz299
White, Harvey D., et al. "Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial." European Heart Journal, vol. 40, br. 33, 2019, str. 2801-2809. https://doi.org/10.1093/eurheartj/ehz299
White, Harvey D., Ph. Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Jay M. Edelberg, et al. "Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial." European Heart Journal 40, br. 33 (2019): 2801-2809. https://doi.org/10.1093/eurheartj/ehz299
White, H. D., et al. (2019) 'Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial', European Heart Journal, 40(33), str. 2801-2809. doi: 10.1093/eurheartj/ehz299
White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, i sur.. Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. European Heart Journal [Internet]. 01.09.2019. [pristupljeno 12.02.2025.];40(33):2801-2809. doi: 10.1093/eurheartj/ehz299
H. D. White, et al., "Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial", European Heart Journal, vol. 40, br. 33, str. 2801-2809, Rujan 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:432371. [Citirano: 12.02.2025.]